Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $133,197 | 40 | 62.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $49,600 | 20 | 23.1% |
| Travel and Lodging | $15,286 | 55 | 7.1% |
| Food and Beverage | $8,971 | 255 | 4.2% |
| Honoraria | $4,550 | 1 | 2.1% |
| Unspecified | $2,450 | 4 | 1.1% |
| Education | $222.50 | 4 | 0.1% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $69,195 | 91 | $0 (2023) |
| Janssen Biotech, Inc. | $41,054 | 44 | $0 (2024) |
| Lilly USA, LLC | $30,492 | 36 | $0 (2024) |
| Eli Lilly and Company | $21,566 | 10 | $0 (2024) |
| Arcutis Biotherapeutics, Inc. | $11,065 | 8 | $0 (2024) |
| Regeneron Pharmaceuticals, Inc. | $10,443 | 10 | $0 (2022) |
| Janssen Scientific Affairs, LLC | $10,162 | 4 | $0 (2024) |
| GENZYME CORPORATION | $7,775 | 6 | $0 (2023) |
| Dermavant Sciences, Inc. | $3,268 | 3 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $2,967 | 15 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $84,834 | 77 | Janssen Biotech, Inc. ($40,839) |
| 2023 | $37,655 | 20 | Lilly USA, LLC ($11,260) |
| 2022 | $16,506 | 8 | Eli Lilly and Company ($6,400) |
| 2021 | $8,040 | 4 | PFIZER INC. ($5,820) |
| 2019 | $16,608 | 21 | Regeneron Pharmaceuticals, Inc. ($9,263) |
| 2018 | $30,466 | 117 | PFIZER INC. ($28,898) |
| 2017 | $20,168 | 132 | PFIZER INC. ($17,365) |
All Payment Transactions
379 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | Eli Lilly and Company | — | Consulting Fee | Cash or cash equivalent | $2,800.00 | General |
| 11/23/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Consulting Fee | Cash or cash equivalent | $6,800.00 | General |
| Category: Immunology | ||||||
| 11/22/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Travel and Lodging | Cash or cash equivalent | $70.47 | General |
| Category: Immunology | ||||||
| 11/22/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | Cash or cash equivalent | $25.52 | General |
| Category: Immunology | ||||||
| 11/22/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | Cash or cash equivalent | $12.96 | General |
| Category: Immunology | ||||||
| 11/19/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Travel and Lodging | Cash or cash equivalent | $166.88 | General |
| Category: Immunology | ||||||
| 11/19/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | Cash or cash equivalent | $18.64 | General |
| Category: Immunology | ||||||
| 11/19/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | Cash or cash equivalent | $17.25 | General |
| Category: Immunology | ||||||
| 11/18/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,950.00 | General |
| Category: Immunology | ||||||
| 11/15/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $51.11 | General |
| Category: Immunology | ||||||
| 11/15/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $37.04 | General |
| Category: Immunology | ||||||
| 11/15/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $19.45 | General |
| Category: Immunology | ||||||
| 11/14/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Travel and Lodging | In-kind items and services | $433.83 | General |
| Category: Immunology | ||||||
| 11/14/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Travel and Lodging | In-kind items and services | $249.66 | General |
| Category: Immunology | ||||||
| 11/14/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Travel and Lodging | In-kind items and services | $231.91 | General |
| Category: Immunology | ||||||
| 11/14/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $118.65 | General |
| Category: Immunology | ||||||
| 11/02/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $57.93 | General |
| Category: Immunology | ||||||
| 11/02/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $38.73 | General |
| Category: Immunology | ||||||
| 11/02/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $38.30 | General |
| Category: Immunology | ||||||
| 11/01/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Travel and Lodging | In-kind items and services | $540.46 | General |
| Category: Immunology | ||||||
| 11/01/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Travel and Lodging | In-kind items and services | $298.64 | General |
| Category: Immunology | ||||||
| 11/01/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $149.69 | General |
| Category: Immunology | ||||||
| 10/28/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $850.00 | General |
| Category: Immunology | ||||||
| 10/05/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,700.00 | General |
| Category: Immunology | ||||||
| 09/30/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Consulting Fee | Cash or cash equivalent | $1,700.00 | General |
| Category: Immunology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| ABROCITINIB CLINICAL PUBLICATION PROGRAM | PFIZER INC. | $1,270 | 2 |
| DUPIXENT CLINICAL DEVELOPMENT PROGRAM | Regeneron Pharmaceuticals, Inc. | $1,180 | 2 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 93 | 105 | $23,250 | $9,744 |
| 2022 | 3 | 152 | 192 | $40,990 | $15,323 |
| 2021 | 4 | 160 | 193 | $42,800 | $17,929 |
| 2020 | 3 | 67 | 76 | $12,290 | $4,968 |
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 21 | 27 | $5,400 | $2,846 | 52.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 20 | 20 | $6,000 | $2,410 | 40.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 25 | 30 | $6,000 | $2,228 | 37.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 13 | 13 | $3,900 | $1,345 | 34.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 14 | 15 | $1,950 | $914.40 | 46.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 45 | 69 | $13,800 | $5,066 | 36.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 30 | 41 | $8,200 | $3,439 | 41.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 31 | 31 | $9,300 | $2,774 | 29.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 18 | 18 | $5,400 | $2,070 | 38.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 17 | 21 | $2,730 | $1,289 | 47.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 11 | 12 | $1,560 | $684.30 | 43.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 32 | 49 | $9,800 | $5,168 | 52.7% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 26 | 26 | $7,800 | $3,664 | 47.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 31 | 43 | $8,600 | $3,291 | 38.3% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 25 | 25 | $7,500 | $2,414 | 32.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 21 | 24 | $3,120 | $1,829 | 58.6% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 13 | 13 | $4,290 | $983.62 | 22.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 12 | 13 | $1,690 | $580.00 | 34.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 25 | 28 | $5,600 | $2,255 | 40.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 27 | 33 | $4,290 | $2,013 | 46.9% |
| 99202 | New patient office or other outpatient visit, typically 20 minutes | Office | 2020 | 15 | 15 | $2,400 | $699.90 | 29.2% |
About Dr. Candrice Heath, MD
Dr. Candrice Heath, MD is a Dermatology healthcare provider based in Washington, District of Columbia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/18/2007. The National Provider Identifier (NPI) number assigned to this provider is 1346436052.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Candrice Heath, MD has received a total of $214,277 in payments from pharmaceutical and medical device companies, with $84,834 received in 2024. These payments were reported across 379 transactions from 33 companies. The most common payment nature is "Consulting Fee" ($133,197).
As a Medicare-enrolled provider, Heath has provided services to 472 Medicare beneficiaries, totaling 566 services with total Medicare billing of $47,963. Data is available for 4 years (2020–2023), covering 21 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Other Specialties Dermatology, Pediatrics
- Location Washington, DC
- Active Since 09/18/2007
- Last Updated 04/03/2024
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1346436052
Products in Payments
- TREMFYA (Drug) $50,939
- EUCRISA (Drug) $50,550
- DUPIXENT (Biological) $16,787
- CIBINQO (Drug) $6,162
- INFLECTRA (Biological) $4,200
- VTAMA (Drug) $3,268
- Zoryve (Drug) $2,411
- Humira (Biological) $694.42
- XALKORI (Drug) $438.00
- Levulan (Drug) $412.70
- Odomzo (Drug) $364.06
- DUPIXENT DUPILUMAB INJECTION (Biological) $282.44
- Enbrel (Biological) $280.02
- EPIDUO FORTE (Drug) $259.69
- Otezla (Drug) $229.14
- ENSTILAR (Drug) $215.50
- STELARA (Biological) $160.56
- ORACEA (Drug) $157.75
- Tremfya (Drug) $115.64
- TALTZ (Drug) $82.35
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Washington
Dr. Jonathan Silverberg, Md, Phd, Mph, MD, PHD, MPH
Dermatology — Payments: $4.9M
Dr. Adam Friedman, M.d, M.D
Dermatology — Payments: $1.8M
Dr. Terrence Keaney, M.d, M.D
Dermatology — Payments: $1.1M
Mary Ruth Buchness, Md, MD
Dermatology — Payments: $150,119
Dr. Todd Perkins, Md, MD
Dermatology — Payments: $117,310
Dr. Yolanda Holmes, Md, MD
Dermatology — Payments: $107,834